FLEXiGUT: Rationale for exposomics associations with chronic low-grade gut inflammation

dc.contributor.authorPeró Gascón, Roger
dc.contributor.authorHemeryck, L. Y.
dc.contributor.authorPoma, G.
dc.contributor.authorFalony, G.
dc.contributor.authorNawrot, T.S.
dc.contributor.authorRaes, J.
dc.contributor.authorVanhaecke, L.
dc.contributor.authorDe Boevre, M.
dc.contributor.authorCovaci, A.
dc.contributor.authorDe Saeger,S.
dc.date.accessioned2025-02-13T13:33:26Z
dc.date.available2025-02-13T13:33:26Z
dc.date.issued2022
dc.date.updated2025-02-13T13:33:26Z
dc.description.abstractFLEXiGUT is the first large-scale exposomics study focused on chronic low-grade inflammation. It aims to characterize human life course environmental exposure to assess and validate its impact on gut inflammation and related biological processes and diseases. The cumulative influences of environmental and food contaminants throughout the lifespan on certain biological responses related to chronic gut inflammation will be investigated in two Flemish prospective cohorts, namely the “ENVIRONAGE birth cohort”, which provides follow-up from gestation to early childhood, and the “Flemish Gut Flora Project longitudinal cohort”, a cohort of adults. The exposome will be characterised through biomonitoring of legacy and emerging contaminants, mycotoxins and markers of air pollution, by analysing the available metadata on nutrition, location and activity, and by applying state-of-the-art -omics techniques, including metagenomics, metabolomics and DNA adductomics, as well as the assessment of telomere length and measurement of inflammatory markers, to encompass both exposure and effect. Associations between exposures and health outcomes will be uncovered using an integrated -omics data analysis framework comprising data exploration, pre-processing, dimensionality reduction and data mining, combined with machine learning-based pathway analysis approaches. This is expected to lead to a more profound insight in mechanisms underlying disease progression (e.g. metabolic disorders, food allergies, gastrointestinal cancers) and/or accelerated biological ageing.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec716722
dc.identifier.issn0160-4120
dc.identifier.urihttps://hdl.handle.net/2445/218743
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.envint.2021.106906
dc.relation.ispartofEnvironment International, 2022, vol. 158, p. 1-9
dc.relation.urihttps://doi.org/10.1016/j.envint.2021.106906
dc.rightscc-by-nc-nd (c) Peró Gascón, Roger, et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Enginyeria Química i Química Analítica)
dc.subject.classificationMicotoxines
dc.subject.classificationAl·lèrgia alimentària
dc.subject.classificationMetabolòmica
dc.subject.otherMycotoxins
dc.subject.otherFood allergy
dc.subject.otherMetabolomics
dc.titleFLEXiGUT: Rationale for exposomics associations with chronic low-grade gut inflammation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
243965.pdf
Mida:
1.43 MB
Format:
Adobe Portable Document Format